[Translated article] Benefits of analgesic blocks, PENG block (PEricapsular Nerve Group), in fast recovery after hip surgery

Autor: Martínez Martín, A., Pérez Herrero, M., Sánchez Quirós, B., López Herrero, R., Ruiz Bueno, P., Cocho Crespo, S.

Publikováno v: In Revista Espanola de Cirugia Ortopedica y Traumatologia January-February 2023 67(1):T27-T34

Clinical, Histological, and HPV-Related Factors Associated to Diffuse Presentation of Exophytic Nasal Papillomas.

Autor: Fulla M; Department of Otorhinolaryngology, Hospital Universitari Bellvitge, 08907 L'Hospitalet de Llobregat, Spain.; Program of Molecular Mechanisms and Experimental Therapy in Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain., Quiros B; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), 08907 L'Hospitalet de Llobregat, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Clavero O; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), 08907 L'Hospitalet de Llobregat, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Gomà M; Program of Molecular Mechanisms and Experimental Therapy in Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Department of Pathology, Hospital Universitari Bellvitge, 08907 L'Hospitalet de Llobregat, Spain., de Andrés-Pablo Á; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), 08907 L'Hospitalet de Llobregat, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain., Pavon MÀ; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), 08907 L'Hospitalet de Llobregat, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Penella A; Department of Otorhinolaryngology, Hospital Universitari Bellvitge, 08907 L'Hospitalet de Llobregat, Spain.; Program of Molecular Mechanisms and Experimental Therapy in Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain., Alemany L; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), 08907 L'Hospitalet de Llobregat, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., González-Compta X; Department of Otorhinolaryngology, Hospital Universitari Bellvitge, 08907 L'Hospitalet de Llobregat, Spain.; Program of Molecular Mechanisms and Experimental Therapy in Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Faculty of Medicine, University of Barcelona, 08907 Barcelona, Spain., Mena M; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), 08907 L'Hospitalet de Llobregat, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Publikováno v: Journal of clinical medicine [J Clin Med] 2024 Nov 05; Vol. 13 (22). Date of Electronic Publication: 2024 Nov 05.

Concordance of p16(INK4a) and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study

Autor: Mena, M, Wang, X, Tous, S, Quiros, B, Clavero, O, Alejo, M, Morey, F, Taberna, M, Vintro, XL, Rubio, BL, Alos, L, Mehanna, H, Quint, W, Pawlita, M, Tommasino, M, Pavon, MA, Munoz, N, De Sanjose, S, Bosch, FX, Alemany, L

Publikováno v: Cancers
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Simple Summary The utility of a diagnostic algorithm for the detection of HPV-driven oral cavity (OCC), oropharyngeal (OPC), and laryngeal (LC) carcinomas using HPV-DNA testing followed by p16(INK4a) immunohistochemistry, taking E6*I mRNA detection a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::d69f197bd0647a1776108b3e5008aeae
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12269

899P Impact of COVID-19 pandemic on treatment and survival in head and neck squamous cell carcinoma (HNSCC) patients (IMPACCT Study)

Autor: Vilar Anglada, B., Guillén Sentís, P., Castillo Manzano, C., Brenes Castro, J., Morey, F., Tous, S., Quirós, B., Plana Serrahima, M., Lozano, A., Linares Galiana, I., Vilajosana, E., Godino, C., Labori, M., Goma, M., Marí, A., Bermejo, O., Fulla, M., Alemany, L., Oliva, M.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S573-S574

Anaesthetic management of a dopamine-secreting phaeochromocytoma

Autor: López Herrero, R., Rodríguez Jiménez, R.P., Sánchez Quirós, B.

Publikováno v: In Revista Española de Anestesiología y Reanimación (English Edition) April 2022 69(4):249-252